Offering the Appropriate Patient the Opportunity for Treatment with TRK Inhibitors

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD; Arturo Loaiza-Bonilla, MD, MSEd, FACP

Video Categories: NTRK Gene Fusions

Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, discuss who may and may not be appropriate candidates for TRK inhibitor therapy.

November 24, 2014

Patients Understanding their Cancer and Treatment Options

Gary Palmer, MD, discusses the importance of patients knowing the DNA drivers of their cancer to slow the growth of their cancer.

November 3, 2014

Referrals for Patients with Polycythemia Vera

Dr. Mesa describes why patients with PV who have a broad and heterogeneous course should seek a referral from a specialty center.Supported through funding from Incyte